{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:21:51Z","timestamp":1762251711530},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.euroneuro.2010.12.005","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T09:25:30Z","timestamp":1296120330000},"page":"450-456","source":"Crossref","is-referenced-by-count":26,"title":["Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity"],"prefix":"10.1016","volume":"21","author":[{"given":"Fabio","family":"Caputo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Francini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romeo","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Vigna-Taglianti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Stoppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arfedele","family":"Del Re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Leggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Addolorato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Zoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2010.12.005_bb0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/13543780902905855","article-title":"The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data","volume":"18","author":"Addolorato","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/alcalc\/33.5.465","article-title":"Gamma-hydroxybutyric acid reducing effect on ethanol intake: evidence in favour of a substitution mechanism","volume":"33","author":"Agabio","year":"1998","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0020","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cpr.2005.05.005","article-title":"Impulsivity as a common process across borderline personality and substance use disorders","volume":"25","author":"Bornovalova","year":"2005","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0025","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.2174\/138161210791516468","article-title":"Medications acting on the GABA system in the treatment of alcoholic patients","volume":"16","author":"Caputo","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0376-8716(02)00340-X","article-title":"Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study","volume":"70","author":"Caputo","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0035","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3390\/ijerph6061917","article-title":"Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review","volume":"6","author":"Caputo","year":"2009","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/0269881108094620","article-title":"Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study","volume":"23","author":"Caputo","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0045","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1521\/pedi.16.5.424.22124","article-title":"Dependency, impulsivity, and self-harm: traits hypothesized to underlie the association between cluster B personality and substance use disorders","volume":"16","author":"Casillas","year":"2002","journal-title":"J. Personal. Disord."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0050","first-page":"869","article-title":"Cigarette smoking among adults\u2014United States, 1999, MMWR","volume":"50","author":"Centers for Disease Prevention Control (CDC)","year":"2001","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(94)00687-3","article-title":"Cross-tolerance to ethanol and gamma-hydroxybutyric acid","volume":"273","author":"Colombo","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.v67n0211","article-title":"Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"67","author":"Conway","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0065","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.addbeh.2004.06.004","article-title":"Reward drive and rash impulsiveness as dimensions of impulsivity: implications for substance misuse","volume":"29","author":"Dawe","year":"2004","journal-title":"Addict. Behav."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1530-0277.1992.tb00658.x","article-title":"gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study","volume":"16","author":"Gallimberti","year":"1992","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0741-8329(99)00091-9","article-title":"Mechanism of the anti-alcohol effect of gamma-hydroxybutyric acid (GHB)","volume":"20","author":"Gessa","year":"2000","journal-title":"Alcohol"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0080","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0024-3205(01)01526-0","article-title":"Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain","volume":"70","author":"Gobaille","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0085","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2004.08.004","article-title":"Advances in vivo imaging of serotonergic neurons in neuropsychiatric disorders","volume":"28","author":"Hesse","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0095","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.biopsych.2004.06.034","article-title":"The epidemiology of dual diagnosis","volume":"56","author":"Kessler","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.ALC.0000113413.37910.D7","article-title":"Pharmacological treatment of alcohol abuse\/dependence with psychiatric comorbidity","volume":"28","author":"Le Fauve","year":"2004","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0105","first-page":"157","article-title":"Review and discussion of statistical analysis of controlled clinical trials in alcoholism","volume":"28","author":"Lehert","year":"1993","journal-title":"Alcohol Alcohol."},{"issue":"2","key":"10.1016\/j.euroneuro.2010.12.005_bb0110","first-page":"CD006266","article-title":"Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses","volume":"17","author":"Leone","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2005.09.027","article-title":"Alcohol dependence and gene x environment interaction in emotion regulation: is serotonin the link?","volume":"526","author":"Lesch","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.108.062984","article-title":"Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials","volume":"196","author":"Lieb","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0125","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJM199802263380907","article-title":"Patients with alcohol problems","volume":"338","author":"O'Connor","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0130","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence","volume":"49","author":"O'Malley","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0135","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00023210-200620120-00004","article-title":"gamma-Hydroxybutyrate\/GHB: neurobiology, and impact on sleep and wakefulness","volume":"20","author":"Pardi","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0140","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.biopsych.2005.02.016","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders","volume":"57","author":"Petrakis","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0145","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.biopsych.2006.03.074","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder","volume":"60","author":"Petrakis","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/jcp.0b13e3180337fcb","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and current depression","volume":"27","author":"Petrakis","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0155","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1530-0277.2007.00336.x","article-title":"Treatments for patients with dual diagnosis: a review","volume":"31","author":"Queyen","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/10550490701643336","article-title":"The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders","volume":"16","author":"Ralevski","year":"2007","journal-title":"Am. J. Addictions."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0165","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/S0140-6736(05)66737-2","article-title":"Recognition and management of complications of new recreational drug use","volume":"365","author":"Ricaurte","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0170","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1056\/NEJMra044047","article-title":"Gamma-hydroxybutyric acid","volume":"352","author":"Snead","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2010.12.005_bb0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-3956(03)00050-5","article-title":"Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter","volume":"37","author":"Stockmeier","year":"2003","journal-title":"J. Psychiatr. Res."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X10002816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X10002816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:15:40Z","timestamp":1685924140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X10002816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0924977X10002816"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2010.12.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}